Development of liver regenerative therapy using glycoside-modified bone marrow cells

Ryosuke Misawa, Hirohiko Ise, Masafumi Takahashi, Hajime Morimoto, Eiji Kobayashi, Shin Ichi Miyagawa, Uichi Ikeda

研究成果: Contribution to journalArticle査読

14 被引用数 (Scopus)

抄録

Several recent studies have reported that bone marrow cells (BMCs) have the ability to generate functional hepatocytes. However, the efficiency at which BMC transplantation generates functional hepatocytes is rather low. We assumed that if BMCs accumulated directly in liver, the functional BMC-derived hepatocytes should increase efficiently. We tried to increase the accumulation of BMCs directly in liver through the interaction between hepatic asialoglycoprotein receptor and desialylated BMCs. Desialylated BMCs were produced with treatment of neuraminidase. Desialylated BMCs that expressed green fluorescent protein (GFP) were injected into Long Evans Cinnamon (LEC) rats, a human Wilson's disease model, intravenously. At 3 and 5 months after transplantation, GFP-expressing hepatocyte nodules appeared in the liver of these BMC-transplanted LEC rats. These findings suggest that the functional BMC-derived hepatocytes can be generated by the direct accumulation of BMCs and that this strategy is new BMC therapy for liver regeneration.

本文言語英語
ページ(範囲)434-440
ページ数7
ジャーナルBiochemical and Biophysical Research Communications
342
2
DOI
出版ステータス出版済み - 4 7 2006
外部発表はい

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

フィンガープリント 「Development of liver regenerative therapy using glycoside-modified bone marrow cells」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル